VANGUARD GROUP INC 13D and 13G filings for Ocular Therapeutix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-12 4:49 pm Unchanged | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 8,384,183 5.370% | 0 (Unchanged) | Filing |
| 2024-11-04 1:42 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 8,384,183 5.370% | 3,266,081 (+63.81%) | Filing |
| 2024-02-13 5:09 pm Purchase | 2023-12-29 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 5,118,102 4.460% | 1,141,249 (+28.70%) | Filing |
| 2023-02-09 11:27 am Sale | 2022-12-30 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 3,976,853 5.160% | -102,170 (-2.50%) | Filing |
| 2022-02-10 08:28 am Purchase | 2021-12-31 | 13G | Ocular Therapeutix, Inc. OCUL | VANGUARD GROUP INC | 4,079,023 5.320% | 4,079,023 (New Position) | Filing |